TIROFIBAN G.E.S. EFG 0,05 mg/ml 1 bossa sol perfussió 250 ml Andorra - English - CedimCat (Centre d'Informació de Medicaments de Catalunya)

tirofiban g.e.s. efg 0,05 mg/ml 1 bossa sol perfussió 250 ml

AGGRASTAT Israel - English - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

AGRASTAT 0.25 MG/ML SOLUCIÓN INYECTABLE I.V. Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

agrastat 0.25 mg/ml solución inyectable i.v.

aspen labs, s.a. de c.v. - tirofibÁn (clorhidrato monohidrato) - tirofibÁn (clorhidrato monohidrato)....0.25 mg

Tirofiban Ibisqus 50 Mikrogramm/ml Infusionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

tirofiban ibisqus 50 mikrogramm/ml infusionslösung

Aggrastat New Zealand - English - Medsafe (Medicines Safety Authority)

aggrastat

merck sharp & dohme (new zealand) limited - tirofiban hydrochloride monohydrate 0.05618 mg/ml equivalent to 0.05 mg/ml tirofiban - solution for infusion - 0.05 mg/ml - active: tirofiban hydrochloride monohydrate 0.05618 mg/ml equivalent to 0.05 mg/ml tirofiban excipient: citric acid hydrochloric acid sodium chloride sodium citrate dihydrate sodium hydroxide water for injection

AGGRASTAT Solution for Infusion 0.05mg/ml Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

aggrastat solution for infusion 0.05mg/ml mg/ml

iroko cardio (uk) ltd - tirofiban hydrochloride monohydrate - solution for infusion - 0.05mg/ml mg/ml

AGGRASTAT Israel - English - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate 0.25 mg/ml - solution for infusion - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Aggrastat 50mcg/ml Solution for Infusion Malta - English - Medicines Authority

aggrastat 50mcg/ml solution for infusion

correvio (uk) limited - tirofiban hydrochloride monohydrate 50 µg/ml - solution for infusion

Aggrastat Solution For Infusion 0.25 mg/ml Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

aggrastat solution for infusion 0.25 mg/ml

al jishi pharmacy - tirofiban hydrochloride monohydrate - solution for infusion - 0.25

Aggrastat 250 mcg/mL Concentrate For Infusion Philippines - English - FDA (Food And Drug Administration)

aggrastat 250 mcg/ml concentrate for infusion

aspen philippines, inc. - tirofiban hydrochloride - concentrate for infusion - 250 mcg/ml